Could nasal irrigation and oral rinse reduce the risk for COVID-19 infection?


Journal

International journal of immunopathology and pharmacology
ISSN: 2058-7384
Titre abrégé: Int J Immunopathol Pharmacol
Pays: England
ID NLM: 8911335

Informations de publication

Date de publication:
Historique:
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 28 8 2020
Statut: ppublish

Résumé

Public health measures are essential to protect against COronaVIrus Disease 2019 (COVID-19). The nose and the mouth represent entry portals for the COVID 19. Saline Nasal Irrigations (SNIs) can reduce the viral load in the nasal cavities. Oral rinse with antimicrobial agents is efficacious in reducing the viral load in oral fluids. We advocate the inclusion of SNIs and ethanol oral rinses as additional measures to the current public health measures, to prevent and control the transmission of any respiratory infectious disease, including COVID-19.

Identifiants

pubmed: 32799596
doi: 10.1177/2058738420941757
pmc: PMC7436790
doi:

Substances chimiques

Mouthwashes 0
Ethanol 3K9958V90M

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

2058738420941757

Références

Sci Rep. 2019 Jan 31;9(1):1015
pubmed: 30705369
Dermatol Ther. 2020 Mar 13;:e13310
pubmed: 32170800
J Clin Periodontol. 2005 Apr;32(4):341-6
pubmed: 15811049
Acta Otolaryngol. 2004 Nov;124(9):1059-62
pubmed: 15513550
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Lancet. 2020 Mar 14;395(10227):e49-e50
pubmed: 32119824
Med J Aust. 2020 Jun;212(10):472-481
pubmed: 32356900
Sci Rep. 2018 Sep 11;8(1):13630
pubmed: 30206371
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
J Infect Dis. 2017 Mar 15;215(6):902-906
pubmed: 28453839
Eur Respir J. 2001 Dec;18(6):965-70
pubmed: 11829103
Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418802676
pubmed: 30350744
Arch Otolaryngol Head Neck Surg. 2008 Jan;134(1):67-74
pubmed: 18209140

Auteurs

Manuele Casale (M)

Unit of Otolaryngology, Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

Vittorio Rinaldi (V)

Unit of Otolaryngology, Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

Lorenzo Sabatino (L)

Unit of Otolaryngology, Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

Antonio Moffa (A)

Unit of Otolaryngology, Integrated Therapies in Otolaryngology, Campus Bio-Medico University, Rome, Italy.

Massimo Ciccozzi (M)

Medical Statistics and Epidemiology Unit, Campus Bio-Medico University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH